Pharmaceuticals & Healthcare Decarbonization

Map and quantify emissions across complex, multi-tiered pharmaceutical supply chains to identify high-impact opportunities:

• Measure Scope 3 emissions using primary, modeled, and hybrid approaches across all material categories
• Conduct product- and supplier-level Life Cycle Assessment (LCA) and Product Carbon Footprint (PCF) calculations
• Identify carbon hotspots across purchased APIs, excipients, packaging, logistics, and capital equipment
• Prioritize high-impact intervention areas aligned with procurement volumes and strategic supplier relationships

Design science-based strategies aligned with SBTi and tailored carbon reduction roadmaps for pharmaceutical and healthcare operations:

• Conduct peer benchmarking and materiality assessments
• Design Scope 3 decarbonization strategies and governance frameworks tailored to pharma operating structures
• Support credible science-based target (SBT) setting, SBTi submission, and validation
• Develop phased implementation roadmaps tailored to supplier capabilities and Asia-specific contexts
• Create low-carbon sourcing roadmaps for pharma brands and healthcare procurement teams

Assess energy use, emissions, and decarbonization potential at the facility level to drive implementation:

• Conduct on-site or remote facility energy assessments covering HVAC, compressed air, cleanrooms, steam systems, and sterilization equipment
• Develop detailed action plans with ROI analysis, payback periods, and priority sequencing for each initiative
• Set facility-level carbon and energy reduction targets aligned with company-wide SBTi commitments
• Provide implementation support for energy efficiency upgrades, process improvements, and thermal decarbonization
• Track and verify emission reductions post-implementation using our Carbon Toolkit methodology

Activate supplier action through training, playbooks, and technical assistance across Asian pharma supply chains:

• Segment suppliers by emissions hotspot and strategic importance to prioritize engagement depth
• Deliver training programs, practical playbooks, and capacity-building sessions tailored to Asian manufacturing contexts
• Facilitate facility-level carbon action plans and science-aligned target setting for supplier sites
• Provide technical help-desk support and ongoing engagement to drive implementation
• Design industry-wide collaborative programs that reduce supplier fatigue through standardized methodologies

Deploy low-carbon energy solutions and access green energy options across APAC markets:

• Assess renewable energy options across China, India, Taiwan, South Korea, and Southeast Asia
• Facilitate access to government subsidies and green energy incentives available to manufacturing sites
• Structure onsite solar solutions, Green Energy Certificates (GEC), Renewable Energy Certificates (REC), and Power Purchase Agreements (PPA)
• Design aggregated procurement approaches enabling smaller suppliers to access renewable energy at scale
• Provide ongoing monitoring of renewable energy performance and regulatory developments

Track impact, generate reports, and align with leading frameworks relevant to pharma and healthcare:

• Monitor supplier and facility implementation progress through our Carbon Toolkit and digital management platform
• Generate standardized emissions reports aligned with GHG Protocol, SBTi, CDP, and sector-specific requirements
• Support GHG inventory verification and data assurance through LRQA’s accredited verification capabilities
• Provide benchmarking of facility-level carbon and energy intensity against pharma sector peers